Oracle is making its Health Clinical AI Agent available to NHS trust and private practices. The note-taking software has been piloted at a number of hospital trusts in the UK, including Barts Health ...
Oracle’s remaining performance obligations surged to $523B. This represents roughly 8.5 times annual revenue. Oracle’s trailing free cash flow turned negative at $13B as capital expenditures soared ...
To finance its artificial-intelligence ambitions, Oracle is looking to raise more money at a time when Wall Street has gotten more worried about the level of financing underpinning the AI boom. The ...
Oracle and OpenAI have plans to build $500 billion of data centers in a venture called Stargate. JPMorgan Chase has seen slower investor interest for $38 billion of debt tied to two Stargate sites.
Harry is a Writer, Editor, and Content Strategist from Portsmouth, United Kingdom. He started writing about games as the Editor of his university website, and in the ten years since, he has been ...
Michael Burry, the famed investor who has drawn attention in recent months for criticism of the artificial intelligence boom, is betting against Oracle Corp. Burry owns put options on Oracle shares, ...
Oracle (ORCL) has shown significant rallies in its history. In 2025, it experienced more than a 50% increase within two months. Moreover, there were seven occasions when ORCL appreciated over 30% in ...
Oracle Corporation (NYSE:ORCL) is one of the most active US stocks to buy according to analysts. On December 15, Phillip Securities lowered the firm’s price target on Oracle to $344 from $350 and ...
Oracle (ORCL) stock dropped over 40% from its September peak of $877B valuation. Oracle’s $300B OpenAI contract assumes spending Oracle cannot guarantee. Oracle’s remaining performance obligations hit ...
Larry Ellison’s Oracle is stumbling into the end of the year with its shares taking a beating. The tech firm’s stock has plummeted 30% so far this quarter, CNBC noted Friday. Only four trading days ...
Hosted on MSN
Oracle Japan posts modest profit growth on higher sales, keeps full-year outlook unchanged
An update from Oracle Japan ( (JP:4716)) is now available. Oracle Japan reported non-consolidated interim results for the six months to November 30, 2025, with net sales rising 7.5% year on year to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results